Optiscan Imaging Ltd has released a press release.
Market Update
Filed with ASX ·
On 6ix: 6ix.com/news/market-update-236
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- ZEISS CONVIVO and Appointment of Interim Executive Chairman
- Appendix 4D and Financial Statements - 31 Dec 2017
- Update on CEO Recruitment and Interim Management
- Market Update - Resignation of CEO
- ViewnVivo installed for evaluation at Stanford University
Later from Optiscan Imaging
- Appendix 4E and 2018 Annual Report
- Clinical Trial - Assessment of Breast Cancer Margin
- Suspension from Official Quotation
- ZEISS achieves another milestone on regulatory pathway
- Reinstatement to Official Quotation
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging